UCB - JAMA Neurology Publishes Phase 3 Study Results on the Efficacy and Safety of FINTEPLA (fenfluramine) Oral Solution for the treatment of seizures associated with Lennox-Gastaut Syndrome (LGS) (02.05.2022)